CONOLOG CORPORATION


SELLING AGENT AGREEMENT 


Dated as of October 23, 2007                


First Montauk Securities Corp. 

Parkway 109 Office Center 

328 Newman Springs Road 

Red Bank, New Jersey 07701 


Gentlemen: 


          Conolog
Corporation (the “Company”) proposes to offer for sale (the “Offering”)
in a private offering pursuant to  Regulation D promulgated under the Securities
Act of 1933, as amended (the “Act”)
(i) up to One Million Three Hundred Fifty Thousand Dollars ($1,350,000) of
shares of the  Company’s common stock, $0.01 par value (the “Common
Stock”) at $1.40 per share; and (ii) share purchase
warrants (the “Warrants”),
to purchase shares of Common Stock (the “Warrant
Shares”). The shares of Common Stock (the “Shares”),
the Warrants and the Warrant Shares are collectively referred to herein as the “Securities”.
This letter agreement shall confirm our agreement concerning  First Montauk Securities
Corp. acting as exclusive selling or placement agent (the “Selling Agent” or “FMSC”)
in connection with the sale of the Securities. 


          1.           Appointment of Selling Agent. 


          On the basis of the representations and warranties contained herein, and subject to the terms and conditions set forth herein, the Company hereby appoints First Montauk Securities Corp. as exclusive
selling agent/placement agent for a period beginning on the date hereof and terminating on November 12, 2007 (unless terminated sooner pursuant to the terms hereof) and grants to FMSC the right to offer, as its agent, the Securities pursuant to the
terms of this Agreement. On the basis of such representations and warranties, and subject to such conditions, FMSC hereby accepts such appointment and agree to use its reasonable best efforts to secure subscribers to purchase subscriptions for the
Securities. The Company understands that the Selling Agent is being retained to obtain subscriptions on a “best efforts” basis and has not guaranteed the sale of any Securities. 


          2.          Terms
of the Offering. 


                       (a)           The Offering shall consist of the (i) Common Stock and (ii) Warrants. The Offering is being made on a “best efforts” basis with
no minimum offering amount of subscriptions, and the parties shall use their reasonable efforts to consummate a closing of subscriptions prior to October 31, 2007 . In the event a subscription is not accepted, such rejected subscription funds will
be returned to the subscriber without interest or deduction. 


                       (b)           The Company has prepared a Securities Purchase Agreement (the “Securities Purchase Agreement”), and form of Warrant to be
delivered to all prospective investors. The Securities Purchase Agreement and form of Warrant, including all supplements, exhibits and appendices thereto and documents delivered therewith, are referred to herein as the “Documents” and
shall include any supplements or amendments in accordance with this Agreement. The Offering shall commence on the date hereof, and shall expire at 3:00 p.m., New York time, on November 12, 2007, 












unless extended as provided above. Such period, as same may be so extended, shall hereinafter be referred to as the “Offering Period.” 


                       (c)           Each prospective investor (“Prospective Investor”) who desires to purchase Securities shall deliver to the Selling Agent the
Securities Purchase Agreement and immediately available funds in the amount necessary to purchase the amount of Securities such Prospective Investor desires to purchase. The Selling Agent shall not have any obligation to independently verify the
accuracy or completeness of any information contained in any Purchase Agreement or the authenticity, sufficiency, or validity of any check delivered by any Prospective Investor in payment for Securities. Purchasers in the Offering shall be
“accredited investors” as determined in accordance with Regulation D.


          3.           Closing/Release of Funds.


          The closing (“Closing”) shall be held at such time as the conditions as provided in the Securities Purchase Agreement have been satisfied. References herein to the actual closing date
thereof shall be referred to as a “Closing Date.” 


          4.           Representations and Warranties of the Selling Agent. 


          The Selling Agent represents and warrants to the Company as follows:


                       (a)           The Selling Agent is duly incorporated and validly existing and in good standing under the laws of its State of incorporation. 


                       (b)           The Selling Agent is, and at the time of each Closing will be, a member in good standing of the NASD. 


                       (c)           Offers and sales of Securities by the Selling Agent will be made only in accordance with this Placement Agreement and in compliance with
the provisions of Regulation D and the Selling Agent will furnish to each investor a copy of the Documents prior to accepting any subscription for the Securities. 


          5.           Compensation. 


                       (a)           The Selling Agent shall be entitled, on the Closing Date, as compensation for its services as Selling Agent under this Agreement, to
selling Commissions payable in cash equal to 10% of the aggregate amount of the Common Stock sold in the Offering, provided the Company has actually received the proceeds of such sales, through subscriptions made by investors introduced by FMSC to
the Company. 


                       (b)           In addition to the compensation payable to the Selling Agent set forth in clause (a) above, the Company shall grant the Selling Agent (or
its assigns, subject to compliance with the terms and conditions of this Section) warrants (“Selling Agent Warrants”) to purchase a number of shares of Common Stock equal to 20% of the shares of Common Stock sold in the Offering and the
Selling Agent Warrants shall have an exercise price equal to the exercise price of the Warrants being issued to the investors. The Selling Agent Warrants shall be exercisable beginning on the Closing 


2












Date of the Offering and continuing for a period of five (5) years thereafter and the Selling Agent shall not be entitled to registration rights with respect to the shares of Common Stock. The Selling Agent Warrants shall allow
for “cashless exercise”. The Selling Agent Warrants may be issued to up to ten employees and/or affiliates of the Selling Agent in such amounts as the Selling Agent shall notify in writing the Company prior to the Closing.


          6.           Representations and Warranties of the Company. 


                       (a)           The Company represents and warrants to, and agrees with, the Selling Agent that: 


                                      (i)           No
Documents or information provided by the Company to the Subscribers, including,
without limitation the Reports (as defined in the  Purchase Agreement), shall
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein
in light of circumstances made therein not misleading.



                                      (ii)          The
Company is, and at all times during the period from the date hereof to and including
the Closing Date will be, a corporation duly  organized, validly existing, and
in good standing under the laws of the State of Delaware, with full corporate
power and authority, and has obtained all necessary consents, authorizations,
approvals, orders, licenses, certificates, and permits and  declarations of and
from, and has made filings with, all federal, state and local authorities, to
own, lease, license, and use its properties and assets and to conduct its business
as presently conducted and/or in any such case where the failure to  have any
of the foregoing would not have a material adverse effect on the Company’s
presently conducted business. As of the date hereof, the Company is, and at all
times during the period from the date hereof to and including the Closing Date,
 duly qualified to do business and is in good standing in every jurisdiction
in which its ownership, leasing, licensing, or use of property and assets or
the conduct of its business makes such qualification necessary except where the
failure to be so  qualified would not have a material adverse effect on the Company’s
business. 


                                      (iii)         As
of the date hereof, except as disclosed in the Documents or the Reports as this
term is defined in the Securities Purchase Agreement,  there is no, and as of
the Closing Date there shall not be any, litigation, arbitration, claim, governmental
or other proceeding (formal or informal), or investigation pending or to the
Company’s knowledge threatened, with respect to the
Company, or its respective operations, businesses, properties, or assets, except
as described in the Purchase Agreement, the Reports or which individually or
in the aggregate do not now have and will not in the future have a material adverse
effect  upon the operations, business, properties, or assets of the Company. 


                                      (iv)          The
Company is not in violation or breach of, or in default with respect to, any
material term of its Certificate of Incorporation or  By-Laws. 


                                      (v)           The
Company has all requisite corporate power and authority to execute, deliver,
and perform this Agreement and to consummate the  transactions contemplated hereby.
All necessary corporate proceedings of the Company have been duly taken to authorize
the execution, delivery, and performance by the Company of this Agreement and
(subject to the Approval (as defined 


3












in the Purchase Agreement) the Purchase Agreement and the consummation of the transactions contemplated hereby and thereby. 


                                       (vi)         The
Selling Agent’s Warrants, when issued and delivered pursuant to the terms
of the Offering shall be duly authorized, validly  issued, fully paid and non-assessable,
without any personal liability attaching to the ownership thereof solely by being
such holder and shall not have been issued in violation of any preemptive rights
of stockholders. 


                                      (vii)           Neither
the Company nor any of its officers, directors, or affiliates, has engaged or
will engage, directly or indirectly, in any act or  activity that may jeopardize
the status of the offering and sale of the Securities as an exempt transaction
under Regulation D of the Securities Act of 1933, as amended. 


          7.           Covenants of the Company. 


          The Company covenants that it will: 


                       (a)           Deliver without charge to the Selling Agent such number of copies of the Documents and any supplement or amendment thereto as may
reasonably be requested by the Selling Agent. 


                       (b)           Notify you promptly of rejection of any subscription. The Company shall not (i) accept subscriptions from, or make sales of Securities to,
any Subscribers who are not, to the Company’s knowledge, accredited investors, or (ii) unreasonably reject any subscription for Securities. 


                       (c)           The Company shall cause, at its cost and expense, all “blue sky” filings related to the Offering and required by applicable law
to be made in due and proper form and substance and in a timely manner as required under the laws of the states in which Securities are sold (“Blue Sky Filings”). In addition, the Company shall cause, at its cost and expense, a Form D
related to the Offering to be filed with the Securities and Exchange Commission (“SEC”) in due and proper form and substance and in a timely manner. The Company shall deliver true and correct copies of all Blue Sky Filings and the Form D,
as filed with the SEC, to the Selling Agent within 15 days of the final closing date.


          8.           Conditions of Closing. 


          The obligations of the Selling Agent pursuant to this Agreement shall be subject, in its discretion, to the continuing accuracy of the representations and warranties of the Company contained herein
and in each certificate and document contemplated under this Agreement to be delivered to the Selling Agent, as of the date hereof and as of the Closing Date, with respect to the performance by the Company of its obligations hereunder, and to the
following conditions: 


                       (a)           At the Closing, the Selling Agent and the Company shall have executed documents in form and substance reasonably acceptable to them.



                       (b)           All proceedings taken in connection with the issuance, sale, and delivery of the Securities shall be satisfactory in form and substance to
FMSC and the Company. 

4











          9.           Termination.


          This Agreement may be terminated by the Selling Agent (i) at anytime in the event the Selling Agent has determined, in good faith, that the Documents fail to contain a material fact required to be
stated therein or necessary to make the statements therein not misleading or (ii) upon three (3) days written notice. The Company may not terminate this Agreement in the absence of a material breach of any covenant, representation or warranty
contained in this Agreement made by the Selling Agent. 


          10.         Indemnification
and Contribution. 


                       (a)           The
Company agrees to indemnify and hold harmless the Selling Agent, its officers,
directors, partners, employees, agents, and counsel, and  each person, if any,
who controls the Selling Agent within the meaning of Section 15 of the Act or
Section 20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), against any and all loss, liability, claim, damage,
and expense whatsoever (which shall include, for all purposes of this Section
10, but not be limited to, attorneys’ fees and any and all expense whatsoever
incurred in investigating, preparing, or defending against any litigation, commenced
or  threatened, or any claim whatsoever and any and all amounts paid in settlement
of any claim or litigation) as and when incurred arising out of, based upon,
or in connection with (i) any untrue statement or alleged untrue statement of
a material fact  contained in the Documents, or any omission or alleged omission
to state a material fact required to be stated therein or necessary to make the
statements therein not misleading, unless such statement or omission was made
in reliance upon and in  conformity with written information furnished to the
Company as stated in Section 10(b) with respect to the Selling Agent expressly
for inclusion in the Documents or (ii) any breach of any representation, warranty,
covenant, or agreement of the  Company contained in this Agreement. The foregoing
agreement to indemnify shall be in addition to any liability the Company may
otherwise have, including liabilities arising under this Agreement. 


          If any action is brought against the Selling Agent or any of its officers, directors, partners, employees, agent, or counsel, or any controlling persons of the Selling Agent (an “indemnified
party”), in respect of which indemnify may be sought against the Company pursuant to the foregoing paragraph, such indemnified party or parties shall promptly notify the Company (the “indemnifying party”) in writing of the institution
of such action (but the failure so to notify shall not relieve the indemnifying party from any liability it may have other than pursuant to this Section 10(a)) and the indemnifying party shall promptly assume the defense of such action, including
the employment of counsel (reasonably satisfactory to such indemnified party or parties) and payment of expenses. Such indemnified party shall have the right to employ its own counsel in any such case, but the fees and expense of such counsel shall
be at the expense of such indemnified party unless the employment of such counsel shall have been authorized in writing by the indemnifying party in connection with the defense of such action or the indemnifying party shall not have promptly
employed counsel satisfactory to such indemnified party or parties to have charge of the defense of such action or such indemnified party or parties shall have reasonably concluded that there may be one or more legal defenses available to it or them
or to other indemnified parties which are different from or additional to those available to one or more of the indemnifying parties, in any of which events such reasonable fees and expenses of one such counsel shall be borne by the indemnifying
party and the indemnifying party shall not have the right to direct the defense of such action on behalf of the indemnified party or parties. Anything in this paragraph to the contrary notwithstanding, the indemnifying party shall not 


5












be liable for any settlement of any such claim or action effected without its written consent. The Company agrees to promptly notify the Selling Agent of the commencement of any litigation or proceedings against the Company or any
of its officers or directors in connection with the sale of the Securities or the Documents.


                       (b)           The
Selling Agent agrees to indemnify and hold harmless the Company, its officers,
directors, employees, agents, and counsel, and each  other person, if any, who
controls the Company within the meaning of Section 15 of the Act or Section 20(a)
of the Exchange Act, to the same extent as the foregoing indemnity from the Company
to the Selling Agent in Section 10(a), with respect to  any and all loss, liability,
claim, damage, and expense whatsoever (which shall include, for all purposes
of this Section 10, but not be limited to, attorneys’ fees and any and all
expense whatsoever incurred in investigating, preparing, or  defending against
any litigation, commenced or threatened, or any claim whatsoever and any and
all amounts paid in settlement of any claim or litigation) as and when incurred
arising out of, based upon, or in connection with (i) statements or  omissions,
if any, made in the Documents in reliance upon and in conformity with written
information furnished to the Company with respect to the Selling Agent expressly
for inclusion in the Documents, and (ii) or any breach of any representation,
 warranty, covenant or agreement of the Selling Agent contained in this Agreement.
If any action shall be brought against the Company or any other person so indemnified
based on the Documents and in respect of which indemnity may be sought against
 the Selling Agent pursuant to this Section, the Selling Agent shall have the
rights and duties given to the indemnifying party, and the Company and each other
person so indemnified shall have the rights and duties given to the indemnified
parties,  by the provisions of Section 10(a) hereof. 


                       (c)           To
provide for just and equitable contribution, if (i) an indemnified party makes
a claim for indemnification pursuant to Section 10(a) or  10(b) hereof but it
is found in a final judicial determination, not subject to further appeal, that
such indemnification may not be enforced in such case, even though this Agreement
expressly provides for indemnification in such case, or (ii) any  indemnified
or indemnifying party seeks contribution under the Act, the Exchange Act, or
otherwise, then the Company (including for this purpose any contribution made
by or on behalf of any officer, director, employee, agent, or counsel of the
 Company, or any controlling person of the Company), on the one hand, and the
Selling Agent (including for this purpose any contribution by or on behalf of
an indemnified party), on the other hand, shall contribute to the losses, liabilities,
claims,  damages, and expenses whatsoever to which any of them may be subject,
in such proportions as are appropriate to reflect the relative benefits received
by the Company, on the one hand, and the Selling Agent, on the other hand; provided,
however, that  if applicable law does not permit such allocation, then other
relevant equitable considerations such as the relative fault of the Company and
the Selling Agent in connection with the facts which resulted in such losses,
liabilities, claims, damages,  and expenses shall also be considered. The relative
benefits received by the Company, on the one hand, and the Selling Agent, on
the other hand, shall be deemed to be in the same proportion as (x) the total
proceeds from the Offering (net of  compensation payable to the Placement Agent
pursuant to Section 5(a) hereof but before deducting expenses) received by the
Company, and (y) the compensation received by the Selling Agent pursuant to Section
5(a) hereof. 


          The relative fault, in the case of an untrue statement, alleged untrue statement, omission, or alleged omission, shall be determined by, among other things, whether such statement, alleged statement,
omission, or alleged omission relates to information supplied by the Company or by the 


6












Selling Agent, and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement, alleged statement, omission, or alleged omission. The Company and the Selling Agent
agree that it would be unjust and inequitable if the respective obligations of the Company and the Selling Agent for contribution were determined by pro rata or per capita allocation of the aggregate losses, liabilities, claims, damages, and
expenses or by any other method of allocation that does not reflect the equitable considerations referred to in this Section 10(c). In no case shall the Selling Agent by responsible for a portion of the contribution obligation in excess of the
compensation received by it pursuant to Section 5(a) hereof. No person guilty of a fraudulent misrepresentation shall be entitled to contribution from any person who is not guilty of such fraudulent misrepresentation. For purposes of this Section
10(c), each person, if any, who controls the Selling Agent within the meaning of Section 15 of the Act or Section 20(a) of the Exchange Act and each officer, director, partners, employee, agent, and counsel of the Selling Agent, shall have the same
rights to contribution as the Selling Agent, and each person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20(a) of the Exchange Act and each officer, director, employee, agent, and counsel of the Company,
shall have the same rights to contribution as the Company, subject in each case to the provisions of this Section 10(c). Anything in this Section 10(c) to the contrary notwithstanding, no party shall be liable for contribution with respect to the
settlement of any claim or action effected without its written consent. 


          11.         Non-Solicitation.


          The Company agrees that, for a period of 12 months from the date hereof (the “Non-Solicitation Period”), it shall not solicit any offer to buy from or offer to sell to any entity listed on
Exhibit “A” any securities of the Company or of any other entity, with any selling agent, placement agent, broker or dealer other than FMSC. In the event that during the Non-Solicitation Period, the Company or any of its affiliates,
directly or indirectly, solicits, offers to buy from or offers to sell to any entity listed on Exhibit “A” any such securities from any other, placement agent, securities broker or dealer or selling agent other than FMSC, the Company shall
pay to the Selling Agent an amount equal to 10% of the aggregate purchase price of such securities so purchased by the purchasers thereof and the Placement Agent shall be entitled to five year warrants entitling the Placement Agent to purchase
shares of Common Stock equal to 20% of the shares of Common Stock (or shares of Common Stock underlying any convertible securities) at an exercise price equal to the price of the securities sold to investors. The warrants shall provide for cashless
exercise. Notwithstanding the foregoing, during the Non-Solicitation Period, the Company shall not give the names of the subscribers to any other broker dealer or selling or placement agent. Notwithstanding anything to the contrary herein, it shall
not be a violation of this Section if the Company includes the names of the entities listed on Exhibit “A” in any public filing made by the Company including but not limited to filings that the Company makes with Securities and Exchange
Commission. Upon receipt of written request by the Selling Agent, the Company shall promptly deliver to the Selling Agent the names of any investors in any offering that the Company completes within 12 months from the date of the Closing.


	          	
12.        	
Representations and Agreements to Survive Delivery for a Period of 

  Two (2) Years from the Date Hereof.

  



          All representations, warranties, covenants, and agreements contained in this Agreement shall be deemed to be representations, warranties, covenants, and agreements at the Closing Date and, such



7












representations and warranties shall remain operative and in full force and effect regardless of any investigation made by or on behalf of the Selling Agent or any indemnified person, or by or on behalf of the Company or any
person or entity which is entitled to be indemnified under Section 10(b), and shall survive for a period of two years from the date hereof. In addition, notwithstanding the foregoing and any election hereunder or any termination of this Agreement,
and whether or not the terms of this Agreement are otherwise carried out, the provisions of Section 10 shall survive for a period of five years from the date hereof. 


          13.         Notices.


          All communications hereunder, except as may be otherwise specifically provided herein, shall be in writing and shall be either (i) mailed by first class mail in which case delivery shall be deemed to
be made three days following deposit in the United States mail; or (ii) sent by overnight courier service in case delivery shall be deemed to be made upon receipt, to: First Montauk Securities Corp., Parkway 109 Office Center, 328 Newman Springs
Road, Red Bank, New Jersey 07701, Attention: Ernest Pellegrino, with a copy to Ellenoff, Grossman & Schole LLP, 370 Lexington Avenue, New York, New York 10017, Attention: Brian C. Daughney, Esq.; Conolog Corporation, 5 Columbia Road, Somerville,
New Jersey 07701, Attention: Robert Benou, with a copy to Sichenzia Ross Friedman Ference LLP, 61 Broadway, New York, NY 10006, Attn: David Manno, Esq. 


          14.         Parties.


          This Agreement shall inure solely to the benefit of, and shall be binding upon, the Selling Agent and the Company and the persons and entities referred to in Section 10 who are entitled to
indemnification or contribution, and their respective successors, legal representatives, and assigns (which shall not include any purchaser, as such, of Securities), and no other person shall have or be construed to have any legal or equitable right
remedy, or claim under or in respect of or by virtue of this Agreement or any provision herein contained. 


          15.         Construction.


          This Agreement shall be construed in accordance with the laws of the State of New York, without giving effect to conflict of laws. 


8












          17.         Counterparts.


          This Agreement may be executed in counterparts, each of which shall constitute an original and all of which, when taken together, shall constitute one agreement. This Agreement may be executed by
facsimile signature and delivered by facsimile transmission. 


          If the foregoing correctly sets forth the understanding between us, please so indicate in the space provided below for that purpose, whereupon this agreement shall constitute a binding agreement
between us. 


  	Very truly yours, 
	 
	CONOLOG CORPORATION 
	 
	 
	By:___________________________ 
	Name: 
	Title: 







Accepted as of the date 

first above written: 

FIRST MONTAUK SECURITIES CORP. 


By: _______________________________

Name: 

Title:


9












Exhibit A


NON-SOLICITATION CLIENTS OF FMSC


Harborview Capital 

Whalehaven Capital Fund

Nite Capital LP 

Alpha Capital Anstalt 

LH Financial 

Greenwich Growth Fund 

Monarch Capital Fund 

Chestnut Ridge Partners 

Osher Capital Partners 

Excalibur Capital 


10